Kehua AI (Shenzhen) Innovative Drug R&D Co., Ltd. — Natural Product Compound Library | Innovative Drug Discovery | Spectral Intelligence | Micro-ED Analysis

Kehua AI (Shenzhen) Innovative Drug R&D Co., Ltd. Healthy Roots Biotechnology (Shenzhen) Co., Limited Joint Development

中文 EN

Home

Products

NP Database

Services

Tech Insights

About

Contact

中文 EN

Plant Sources

Structural Classes

Microbial Sources

Flagship Varieties

Synthetic Compounds

CAS No.	NAME	Molecular Formula	Molecular Weight	Purity	Price	2D Structure
1132661-86-9	Ramipril-d5 CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O	C₂₃H₃₂N₂O₅	421.5	-	Click to inquire
1185238-09-8	Ranitidine-d6 Hydrochloride CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C.Cl	C₁₃H₂₃ClN₄O₃S	356.90	-	Click to inquire
70918-17-1	Doxazosin, (R)- COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC	C₂₃H₂₅N₅O₅	451.5	-	Click to inquire
252570-34-6	rac 4'-Hydroxy Reboxetine CCOC1=C(C=CC(=C1)O)OC(C2CNCCO2)C3=CC=CC=C3	C₁₉H₂₃NO₄	329.4	-	Click to inquire
1343498-72-5	Regorafenib metabolite M4 C1=CC(=C(C=C1NC(=O)NC2=C(C=C(C=C2)OC3=CC(=NC=C3)C(=O)N)F)C(F)(F)F)Cl	C₂₀H₁₃ClF₄N₄O₃	468.8	-	Click to inquire
129791-92-0	Rifalazil CC1C=CC=C(C(=O)NC2=C3C(=C4C(=C(C(=C5C4=C(C(O5)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)O)C)O)C2=O)N=C6C(=CC(=CC6=O)N7CCN(CC7)CC(C)C)O3)C	C₅₁H₆₄N₄O₁₃	941.1	-	Click to inquire
1044909-61-6	Rimonabant-d10 Hydrochloride CC1=C(N(N=C1C(=O)NN2CCCCC2)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(C=C4)Cl.Cl	C₂₂H₂₂Cl₄N₄O	510.3	-	Click to inquire
1035438-80-2	Risedronic Acid-d4 (Major) C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O	C₇H₁₁NO₇P₂	287.14	-	Click to inquire
1160170-00-2	Rivaroxaban diol C1C(OC(=O)N1C2=CC=C(C=C2)N(CCO)C(=O)CO)CNC(=O)C3=CC=C(S3)Cl	C₁₉H₂₀ClN₃O₆S	453.9	-	Click to inquire
1160169-98-1	2-[4-[(5S)-5-[[(5-Chlorothiophene-2-carbonyl)amino]methyl]-2-oxo-1,3-oxazolidin-3-yl]-N-(2-hydroxyethyl)anilino]-2-oxoacetic acid C1C(OC(=O)N1C2=CC=C(C=C2)N(CCO)C(=O)C(=O)O)CNC(=O)C3=CC=C(S3)Cl	C₁₉H₁₈ClN₃O₇S	467.9	-	Click to inquire

C₂₃H₃₂N₂O₅ 421.5

Ranitidine-d6 Hydrochloride

Ranitidine-d6 Hydrochloride

C₁₃H₂₃ClN₄O₃S 356.90

Doxazosin, (R)-

R-DOXAZOSIN INTERMEDIATE

C₂₃H₂₅N₅O₅ 451.5

rac 4'-Hydroxy Reboxetine

rac 4’-Hydroxy Reboxetine

C₁₉H₂₃NO₄ 329.4

Regorafenib metabolite M4

瑞戈非尼杂质 15

C₂₀H₁₃ClF₄N₄O₃ 468.8

C₅₁H₆₄N₄O₁₃ 941.1

Rimonabant-d10 Hydrochloride

氘代盐酸利莫那班

C₂₂H₂₂Cl₄N₄O 510.3

Risedronic Acid-d4 (Major)

Risedronic Acid-d4 (Major)

C₇H₁₁NO₇P₂ 287.14

Rivaroxaban diol

利伐沙班的二元醇（非对映异构体的混合物）

C₁₉H₂₀ClN₃O₆S 453.9

2-[4-[(5S)-5-[[(5-Chlorothiophene-2-carbonyl)amino]methyl]-2-oxo-1,3-oxazolidin-3-yl]-N-(2-hydroxyethyl)anilino]-2-oxoacetic acid

利伐沙班杂质 13

C₁₉H₁₈ClN₃O₇S 467.9

< Previous 1 2 3 4 5 6 7 8 9 10 ... (Current page 576) 16106 Next >

All products and services are for scientific research only. They may not be used for human administration, nor are they supplied to individual consumers.

Address: Room B410, Virtual University Park Key Laboratory Building, No. 1 Yuexing 2nd Road, High-Tech Zone Community, Yuehai Subdistrict, Nanshan District, Shenzhen

Phone: 400-856-5689

Email: kehuaai@kehuaai.com

Kehua AI (Shenzhen) Innovative Drug R&D Co., Ltd.

ICP Record No.: 粤ICP备2024241782号